Rajesh K. Malik
2019
Compensation breakdown
| Non-Equity Incentive Plan | $138,768 |
|---|---|
| Option Awards | $828,195 |
| Salary | $413,000 |
| Other | $8,400 |
| Total | $1,388,363 |
Malik received $828.2K in option awards, accounting for 60% of the total pay in 2019.
Malik also received $138.8K in non-equity incentive plan, $413K in salary and $8.4K in other compensation.
Rankings
In 2019, Rajesh K. Malik's compensation ranked 7,718th out of 13,971 executives tracked by ExecPay. In other words, Malik earned more than 44.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,718 out of 13,971 | 45th |
Division Manufacturing | 3,016 out of 5,698 | 47th |
Major group Chemicals And Allied Products | 1,133 out of 2,197 | 48th |
Industry group Drugs | 966 out of 1,883 | 49th |
Industry Pharmaceutical Preparations | 716 out of 1,395 | 49th |
Pay ratio
| Rajesh K. Malik's Pay | $1,388,363 |
|---|---|
| Median Employee's Pay | $213,060 |
| Pay Ratio | 7to 1 |
In 2019, the annual total compensation of Rajesh K. Malik was $1,388,363.
The annual total compensation of the median employee at G1 Therapeutics was $213,060.
The ratio of Rajesh K. Malik's pay to the pay of median employee was therefore 7 to one.
Malik's colleagues
We found five more compensation records of executives who worked with Rajesh K. Malik at G1 Therapeutics in 2019.
2019
Mark Avagliano
G1 Therapeutics
Chief Business Officer
2019
Mark Velleca
G1 Therapeutics
Chief Executive Officer
2019
Jennifer Moses
G1 Therapeutics
Chief Financial Officer
2019
John Demaree
G1 Therapeutics
Chief Commercial Officer
2019
Barclay Phillips
G1 Therapeutics